Cargando…
Pancreatic cancer survival analysis defines a signature that predicts outcome
Pancreatic ductal adenocarcinoma (PDAC) is the third leading cause of cancer death in the US. Despite multiple large-scale genetic sequencing studies, identification of predictors of patient survival remains challenging. We performed a comprehensive assessment and integrative analysis of large-scale...
Autores principales: | Raman, Pichai, Maddipati, Ravikanth, Lim, Kian Huat, Tozeren, Aydin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6084949/ https://www.ncbi.nlm.nih.gov/pubmed/30092011 http://dx.doi.org/10.1371/journal.pone.0201751 |
Ejemplares similares
-
FXYD5 is a Marker for Poor Prognosis and a Potential Driver for Metastasis in Ovarian Carcinomas
por: Raman, Pichai, et al.
Publicado: (2015) -
Beyond just a tight fortress: contribution of stroma to epithelial-mesenchymal transition in pancreatic cancer
por: Bulle, Ashenafi, et al.
Publicado: (2020) -
Asymmetric microarray data produces gene lists highly predictive of research literature on multiple cancer types
por: Dawany, Noor B, et al.
Publicado: (2010) -
Stroma-targeting strategies in pancreatic cancer: Past lessons, challenges and prospects
por: Polani, Faran, et al.
Publicado: (2021) -
Modular composition predicts kinase/substrate interactions
por: Liu, Yichuan, et al.
Publicado: (2010)